Universal Health International Group Holding Limited provided consolidated earnings guidance for the twelve months ended December 31, 2017. The board of directors of the group expected to record a loss for the twelve months ended 31 December 2017, representing an increment in the loss as compared with the corresponding period of last year. The expected loss recorded for the Period and the increment in the loss as compared with the corresponding period of last year were mainly due to: the market remains at a very low point as a result of the continuous downturn of regional real economy with the Northeastern region in the People's Republic of China experiencing a transition of its second revitalization and the competition has intensified, resulting in a decrease in overall sales of the Group; upstream suppliers were striking for the Certification of the Good Manufacture Practice of Medical Products and hence devoted in upgrading their supplies, leading to an increase in the cost of purchase; meanwhile, during the Period, the Group has applied various promotion initiatives and organized more member events and different promotional campaigns with discounts offered to consumers in order to ease the significant decrease in sales and to maintain relative competitiveness, which resulted in a decrease in the gross margin of the Group for the Period; and the Group has made an analysis on the impact of the macro and industrial economic environment and performed an impairment assessment on goodwill, the Group is expected to make an impairment provision for the goodwill arising from retail and distribution businesses acquired in the previous years accordingly.